Age and interval for screening mammography: Whom do you believe?
The purpose of this article is to help the clinician understand the benefits and limitations of screening mammography in the 40–49 age group. Since the benefit of screening mammography is well established in the literature for the 50–59 age group, comparison of the relevant issues is focused on simi...
Gespeichert in:
Veröffentlicht in: | Seminars in surgical oncology 1996-09, Vol.12 (5), p.281-289 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 289 |
---|---|
container_issue | 5 |
container_start_page | 281 |
container_title | Seminars in surgical oncology |
container_volume | 12 |
creator | Venta, Luz A. Goodhartz, Lori Ann |
description | The purpose of this article is to help the clinician understand the benefits and limitations of screening mammography in the 40–49 age group. Since the benefit of screening mammography is well established in the literature for the 50–59 age group, comparison of the relevant issues is focused on similarities and differences between these two age groups. The incidence of breast cancer, the effectiveness of mammography, and the growth rates of tumors influence the benefit derived from screening. Available data suggest that mammography is equally effective in both age groups, with similar detection rates of minimal cancer (27 vs. 25%). The difference in estimated annual incidence between the 40–49 and the 50–59 age group is only 8%. Since tumor growth rate seems to be faster in the younger age group, screening should be performed annually, starting at 40 years of age, if it is to provide a benefit. © 1996 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/(SICI)1098-2388(199609/10)12:5<281::AID-SSU2>3.0.CO;2-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78449456</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78449456</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4042-1e9f8393d03b6fef2083062a24f4f1843a1626eb4dd7a3180d54f529f82d6c43</originalsourceid><addsrcrecordid>eNqFkE1vEzEQhi0EKqHwE5B8Qu1hU3-vHRAlLKVEKs0hRelt5Oza6cJ-BDsp5N93t4nCASROo9HMPO_oQeickiElhJ2dzCbZ5JQSoxPGtT6hxihizig5pWwk3zFNR6Px5FMym31j7_mQDLPpW5aYJ2hwuHmKBjqVKiGCp8_Rixi_E0KpZPwIHWmdck7lAH0YLx22TYHLZu3Cva2wbwOOeXCuKZslrm1dt8tgV3fbEZ7ftTUuWrxtN3jhqtLdu_OX6Jm3VXSv9vUY3Xy-uMm-JFfTy0k2vkpyQQRLqDNec8MLwhfKO8-I5kQxy4QXnmrBLVVMuYUoitRyqkkhhZesO2KFygU_Rm922FVof25cXENdxtxVlW1cu4mQaiGMkKpbnO8W89DGGJyHVShrG7ZACfRqAXq10GuCXhPs1D6OGUjo1AJ0aqFXCxwIZFNgYDry6_0Lm0XtigN37_JP8q-yctu_Yv-f-o_Qx74jJztyGdfu94Fsww9QKU8lzK8v4evtNb0l6Rw-8gcUQ6JV</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78449456</pqid></control><display><type>article</type><title>Age and interval for screening mammography: Whom do you believe?</title><source>MEDLINE</source><source>Wiley Online Library Journals</source><creator>Venta, Luz A. ; Goodhartz, Lori Ann</creator><creatorcontrib>Venta, Luz A. ; Goodhartz, Lori Ann</creatorcontrib><description>The purpose of this article is to help the clinician understand the benefits and limitations of screening mammography in the 40–49 age group. Since the benefit of screening mammography is well established in the literature for the 50–59 age group, comparison of the relevant issues is focused on similarities and differences between these two age groups. The incidence of breast cancer, the effectiveness of mammography, and the growth rates of tumors influence the benefit derived from screening. Available data suggest that mammography is equally effective in both age groups, with similar detection rates of minimal cancer (27 vs. 25%). The difference in estimated annual incidence between the 40–49 and the 50–59 age group is only 8%. Since tumor growth rate seems to be faster in the younger age group, screening should be performed annually, starting at 40 years of age, if it is to provide a benefit. © 1996 Wiley‐Liss, Inc.</description><identifier>ISSN: 8756-0437</identifier><identifier>EISSN: 1098-2388</identifier><identifier>DOI: 10.1002/(SICI)1098-2388(199609/10)12:5<281::AID-SSU2>3.0.CO;2-9</identifier><identifier>PMID: 8873315</identifier><language>eng</language><publisher>New York: John Wiley & Sons, Inc</publisher><subject>Adult ; Age Factors ; breast neoplasms ; Breast Neoplasms - diagnostic imaging ; Breast Neoplasms - mortality ; Breast Neoplasms - prevention & control ; epidemiology ; Female ; Humans ; Incidence ; mammography ; Mammography - methods ; Mass Screening - methods ; Middle Aged ; Outcome Assessment (Health Care) ; Practice Guidelines as Topic ; public health ; Time Factors</subject><ispartof>Seminars in surgical oncology, 1996-09, Vol.12 (5), p.281-289</ispartof><rights>Copyright © 1996 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4042-1e9f8393d03b6fef2083062a24f4f1843a1626eb4dd7a3180d54f529f82d6c43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291098-2388%28199609%2F10%2912%3A5%3C281%3A%3AAID-SSU2%3E3.0.CO%3B2-9$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291098-2388%28199609%2F10%2912%3A5%3C281%3A%3AAID-SSU2%3E3.0.CO%3B2-9$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8873315$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Venta, Luz A.</creatorcontrib><creatorcontrib>Goodhartz, Lori Ann</creatorcontrib><title>Age and interval for screening mammography: Whom do you believe?</title><title>Seminars in surgical oncology</title><addtitle>Semin. Surg. Oncol</addtitle><description>The purpose of this article is to help the clinician understand the benefits and limitations of screening mammography in the 40–49 age group. Since the benefit of screening mammography is well established in the literature for the 50–59 age group, comparison of the relevant issues is focused on similarities and differences between these two age groups. The incidence of breast cancer, the effectiveness of mammography, and the growth rates of tumors influence the benefit derived from screening. Available data suggest that mammography is equally effective in both age groups, with similar detection rates of minimal cancer (27 vs. 25%). The difference in estimated annual incidence between the 40–49 and the 50–59 age group is only 8%. Since tumor growth rate seems to be faster in the younger age group, screening should be performed annually, starting at 40 years of age, if it is to provide a benefit. © 1996 Wiley‐Liss, Inc.</description><subject>Adult</subject><subject>Age Factors</subject><subject>breast neoplasms</subject><subject>Breast Neoplasms - diagnostic imaging</subject><subject>Breast Neoplasms - mortality</subject><subject>Breast Neoplasms - prevention & control</subject><subject>epidemiology</subject><subject>Female</subject><subject>Humans</subject><subject>Incidence</subject><subject>mammography</subject><subject>Mammography - methods</subject><subject>Mass Screening - methods</subject><subject>Middle Aged</subject><subject>Outcome Assessment (Health Care)</subject><subject>Practice Guidelines as Topic</subject><subject>public health</subject><subject>Time Factors</subject><issn>8756-0437</issn><issn>1098-2388</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1vEzEQhi0EKqHwE5B8Qu1hU3-vHRAlLKVEKs0hRelt5Oza6cJ-BDsp5N93t4nCASROo9HMPO_oQeickiElhJ2dzCbZ5JQSoxPGtT6hxihizig5pWwk3zFNR6Px5FMym31j7_mQDLPpW5aYJ2hwuHmKBjqVKiGCp8_Rixi_E0KpZPwIHWmdck7lAH0YLx22TYHLZu3Cva2wbwOOeXCuKZslrm1dt8tgV3fbEZ7ftTUuWrxtN3jhqtLdu_OX6Jm3VXSv9vUY3Xy-uMm-JFfTy0k2vkpyQQRLqDNec8MLwhfKO8-I5kQxy4QXnmrBLVVMuYUoitRyqkkhhZesO2KFygU_Rm922FVof25cXENdxtxVlW1cu4mQaiGMkKpbnO8W89DGGJyHVShrG7ZACfRqAXq10GuCXhPs1D6OGUjo1AJ0aqFXCxwIZFNgYDry6_0Lm0XtigN37_JP8q-yctu_Yv-f-o_Qx74jJztyGdfu94Fsww9QKU8lzK8v4evtNb0l6Rw-8gcUQ6JV</recordid><startdate>199609</startdate><enddate>199609</enddate><creator>Venta, Luz A.</creator><creator>Goodhartz, Lori Ann</creator><general>John Wiley & Sons, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199609</creationdate><title>Age and interval for screening mammography: Whom do you believe?</title><author>Venta, Luz A. ; Goodhartz, Lori Ann</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4042-1e9f8393d03b6fef2083062a24f4f1843a1626eb4dd7a3180d54f529f82d6c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adult</topic><topic>Age Factors</topic><topic>breast neoplasms</topic><topic>Breast Neoplasms - diagnostic imaging</topic><topic>Breast Neoplasms - mortality</topic><topic>Breast Neoplasms - prevention & control</topic><topic>epidemiology</topic><topic>Female</topic><topic>Humans</topic><topic>Incidence</topic><topic>mammography</topic><topic>Mammography - methods</topic><topic>Mass Screening - methods</topic><topic>Middle Aged</topic><topic>Outcome Assessment (Health Care)</topic><topic>Practice Guidelines as Topic</topic><topic>public health</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Venta, Luz A.</creatorcontrib><creatorcontrib>Goodhartz, Lori Ann</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Seminars in surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Venta, Luz A.</au><au>Goodhartz, Lori Ann</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Age and interval for screening mammography: Whom do you believe?</atitle><jtitle>Seminars in surgical oncology</jtitle><addtitle>Semin. Surg. Oncol</addtitle><date>1996-09</date><risdate>1996</risdate><volume>12</volume><issue>5</issue><spage>281</spage><epage>289</epage><pages>281-289</pages><issn>8756-0437</issn><eissn>1098-2388</eissn><abstract>The purpose of this article is to help the clinician understand the benefits and limitations of screening mammography in the 40–49 age group. Since the benefit of screening mammography is well established in the literature for the 50–59 age group, comparison of the relevant issues is focused on similarities and differences between these two age groups. The incidence of breast cancer, the effectiveness of mammography, and the growth rates of tumors influence the benefit derived from screening. Available data suggest that mammography is equally effective in both age groups, with similar detection rates of minimal cancer (27 vs. 25%). The difference in estimated annual incidence between the 40–49 and the 50–59 age group is only 8%. Since tumor growth rate seems to be faster in the younger age group, screening should be performed annually, starting at 40 years of age, if it is to provide a benefit. © 1996 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley & Sons, Inc</pub><pmid>8873315</pmid><doi>10.1002/(SICI)1098-2388(199609/10)12:5<281::AID-SSU2>3.0.CO;2-9</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 8756-0437 |
ispartof | Seminars in surgical oncology, 1996-09, Vol.12 (5), p.281-289 |
issn | 8756-0437 1098-2388 |
language | eng |
recordid | cdi_proquest_miscellaneous_78449456 |
source | MEDLINE; Wiley Online Library Journals |
subjects | Adult Age Factors breast neoplasms Breast Neoplasms - diagnostic imaging Breast Neoplasms - mortality Breast Neoplasms - prevention & control epidemiology Female Humans Incidence mammography Mammography - methods Mass Screening - methods Middle Aged Outcome Assessment (Health Care) Practice Guidelines as Topic public health Time Factors |
title | Age and interval for screening mammography: Whom do you believe? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T18%3A33%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Age%20and%20interval%20for%20screening%20mammography:%20Whom%20do%20you%20believe?&rft.jtitle=Seminars%20in%20surgical%20oncology&rft.au=Venta,%20Luz%20A.&rft.date=1996-09&rft.volume=12&rft.issue=5&rft.spage=281&rft.epage=289&rft.pages=281-289&rft.issn=8756-0437&rft.eissn=1098-2388&rft_id=info:doi/10.1002/(SICI)1098-2388(199609/10)12:5%3C281::AID-SSU2%3E3.0.CO;2-9&rft_dat=%3Cproquest_cross%3E78449456%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78449456&rft_id=info:pmid/8873315&rfr_iscdi=true |